These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 22334228

  • 1. [Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition].
    Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U.
    Minerva Ginecol; 2012 Feb; 64(1):23-9. PubMed ID: 22334228
    [Abstract] [Full Text] [Related]

  • 2. Effects of three treatment modalities (diet, myoinositol or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome.
    Le Donne M, Metro D, Alibrandi A, Papa M, Benvenga S.
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2293-2301. PubMed ID: 30915778
    [Abstract] [Full Text] [Related]

  • 3. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 4. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.
    Raffone E, Rizzo P, Benedetto V.
    Gynecol Endocrinol; 2010 Apr; 26(4):275-80. PubMed ID: 20222840
    [Abstract] [Full Text] [Related]

  • 5. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 6. Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.
    Ravn P, Haugen AG, Glintborg D.
    Minerva Endocrinol; 2013 Mar; 38(1):59-76. PubMed ID: 23435443
    [Abstract] [Full Text] [Related]

  • 7. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
    Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH.
    Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
    [Abstract] [Full Text] [Related]

  • 8. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS.
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [Abstract] [Full Text] [Related]

  • 9. [Metformin treatment with or without life style changes in patients with polycystic ovary syndrome].
    Petrányi G, Zaoura-Petrányi M.
    Orv Hetil; 2011 Apr 17; 152(16):628-32. PubMed ID: 21454179
    [Abstract] [Full Text] [Related]

  • 10. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA, Khurana ML, Nisar S, Shah PA, Shah ZA, Kulshrestha B, Gupta N, Zargar MA, Wani TA, Mudasir S, Mir FA, Taing S.
    J Clin Endocrinol Metab; 2013 Sep 17; 98(9):3599-607. PubMed ID: 23846820
    [Abstract] [Full Text] [Related]

  • 11. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G, Lorusso F, De Pergola G, Nicolardi V, Mei L, Selvaggi L.
    Gynecol Endocrinol; 2002 Jun 17; 16(3):217-24. PubMed ID: 12192894
    [Abstract] [Full Text] [Related]

  • 12. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C, Cardoza L, Coutiño B, Hidalgo R, Arteaga-Troncoso G, Parra A.
    J Endocrinol; 2005 Jan 17; 184(1):233-9. PubMed ID: 15642799
    [Abstract] [Full Text] [Related]

  • 13. Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.
    Esfahanian F, Zamani MM, Heshmat R, Moini nia F.
    J Obstet Gynaecol Res; 2013 Apr 17; 39(4):806-13. PubMed ID: 23279603
    [Abstract] [Full Text] [Related]

  • 14. Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study.
    Qublan HS, Yannakoula EK, Al-Qudah MA, El-Uri FI.
    Saudi Med J; 2007 Nov 17; 28(11):1694-9. PubMed ID: 17965792
    [Abstract] [Full Text] [Related]

  • 15. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
    Onalan G, Goktolga U, Ceyhan T, Bagis T, Onalan R, Pabuçcu R.
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec 01; 123(2):204-11. PubMed ID: 16316811
    [Abstract] [Full Text] [Related]

  • 16. Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia.
    Glueck CJ, Golnik KC, Aregawi D, Goldenberg N, Sieve L, Wang P.
    Transl Res; 2006 Nov 01; 148(5):215-22. PubMed ID: 17145568
    [Abstract] [Full Text] [Related]

  • 17. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr 01; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of a new association between insulin-sensitizers and α-lipoic acid in obese women affected by PCOS].
    Cappelli V, Di Sabatino A, Musacchio MC, De Leo V.
    Minerva Ginecol; 2013 Aug 01; 65(4):425-33. PubMed ID: 24051942
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
    Trolle B, Flyvbjerg A, Kesmodel U, Lauszus FF.
    Hum Reprod; 2007 Nov 01; 22(11):2967-73. PubMed ID: 17766923
    [Abstract] [Full Text] [Related]

  • 20. The effect of comprehensive lifestyle intervention or metformin on obesity in young women.
    Lim SS, Norman RJ, Clifton PM, Noakes M.
    Nutr Metab Cardiovasc Dis; 2011 Apr 01; 21(4):261-8. PubMed ID: 20163941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.